India’s government may seek legal advice on central licensing for all sterile drugs

The Economic Times reports that India’s government is considering bringing all sterile drug products under central licensing, including injectables and ophthalmic preparations. An advisory committee recommended studying the proposal’s feasibility and seeking a legal opinion before further action. The proposal comes after the Supreme Court declined to overturn a ruling limiting a central drug inspector’s enforcement powers. Some sterile products are currently licensed by state authorities.